BICO Group AB (publ) (BICO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bico Group Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.117 Welcome to BICO Q3 2025 report presentation. 00:00:04.117 -- 00:00:08.663 For the first part of the presentation, participants will be in listen-only mode. 00:00:08.663 -- 00:00:13.410 During the questions and answers session, participants are able to ask questions by dialing 00:00:13.410 -- 00:00:17.897 pound key five on their telephone keypad. Now I will hand the conference over to the 00:00:17.897 -- 00:00:22.163 speakers, CEO Maria Force and CFO Jacob Thordenberg. 00:00:22.163 -- 00:00:24.684 Please go ahead. 00:00:27.233 -- 00:00:31.517 Hello and welcome to BICO Group's Q3 2025 Earnings Call. 00:00:31.517 -- 00:00:36.623 I'm Maria Forbes, President and CEO, and I will, together with BICO's CFO Jakob Thorndenberg, 00:00:36.623 -- 00:00:39.245 present this interim report. 00:00:39.245 -- 00:00:43.730 Here's today's agenda. I will open today's session by presenting how BICO serves the 00:00:43.730 -- 00:00:49.055 world's leading pharma and biotech companies with solutions that transform how labs operate 00:00:49.055 -- 00:00:50.797 and innovate. 00:00:50.797 -- 00:00:54.681 Following that, Jakob will provide a summary of the quarter's key developments and present 00:00:54.681 -- 00:00:57.136 the Group's financial performance. 00:00:57.136 -- 00:01:02.985 We'll proceed and comment on our two business areas, Life Science Solutions and Lab Automation. 00:01:02.985 -- 00:01:07.511 Additionally, we will highlight our R&D pipeline with ongoing product development efforts. 00:01:07.511 -- 00:01:12.716 And this session will conclude with final remarks before opening up for Q&A. 00:01:13.620 -- 00:01:16.865 At Baico, we serve the world's leading pharma biotech companies. 00:01:16.865 -- 00:01:22.073 Our portfolio ranges from Baicero's mar...